Skip to content Skip to footer

Research Portal of the TU Dresden

Lydia Reinhardt
Person

Affiliations

Department of Dermatology
- Academic Staff
- lydia.reinhardt2@mailbox.tu-dresden.de
Department of Internal Medicine I
- Academic Staff
- lydia.reinhardt2@tu-dresden.de
Center for Evidence-Based Healthcare
- Academic Staff
- lydia.reinhardt2@mailbox.tu-dresden.de

Identification Numbers

ORCID	0000-0001-6232-5132
Scopus author ID	57217514023

Related content

Research output

General practitioners' perspectives on statutory skin cancer screening-A questionnaire-based cross-sectional survey in Germany

Reinhardt, L., Strasser, C., Steeb, T., Petzold, A., Heppt, M. V., Wessely, A., Berking, C., & 1 othersMeier, F., Aug 2024, In: PloS one. 19, 8, p. e0308508 e0308508.

Research output: Contribution to journal › Research article › Contributed › peer-review

Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study

Chatziioannou, E., Higuita, L. M. S., Kreft, S., Kandolf, L., Dujovic, B., Reinhardt, L., Tamara, E., & 14 othersMarquez-Rodas, I., Fortuna, A. R. F. P., Nübling, A., Niessner, H., Forschner, A., Garbe, C., Popovic, A., Mirjana, B., Meier, F., Eigentler, T., Leiter, U., Flatz, L., Sinnberg, T. & Amaral, T., Aug 2024, In: ESMO open. 9, 8, 103661.

Research output: Contribution to journal › Research article › Contributed › peer-review

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Ruf, T., Kramer, R., Forschner, A., Leiter, U., Meier, F., Reinhardt, L., Dücker, P., & 12 othersErtl, C., Tomsitz, D., Tietze, J. K., Gutzmer, R., Dabrowski, E., Zimmer, L., Gesierich, A., Zierold, S., French, L. E., Eigentler, T., Amaral, T. & Heinzerling, L., May 2024, In: European journal of cancer. 203, 114028.

Research output: Contribution to journal › Research article › Contributed › peer-review

Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Wagner, N. B., Lenders, M. M., Kühl, K., Reinhardt, L., Fuchß, M., Ring, N., Stäger, R., & 17 othersZellweger, C., Ebel, C., Kimeswenger, S., Oellinger, A., Amaral, T., Forschner, A., Leiter, U., Klumpp, B., Hoetzenecker, W., Terheyden, P., Mangana, J., Loquai, C., Cozzio, A., Garbe, C., Meier, F., Eigentler, T. K. & Flatz, L., Jan 2024, In: European journal of cancer. 196, p. 113425 113425.

Research output: Contribution to journal › Research article › Contributed › peer-review

Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study

Lodde, G. C., Hassel, J., Wulfken, L. M., Meier, F., Mohr, P., Kähler, K., Hauschild, A., & 20 othersSchilling, B., Loquai, C., Berking, C., Hüning, S., Eckardt, J., Gutzmer, R., Reinhardt, L., Glutsch, V., Nikfarjam, U., Erdmann, M., Beckmann, C. L., Stang, A., Kowall, B., Galetzka, W., Roesch, A., Ugurel, S., Zimmer, L., Schadendorf, D., Forschner, A. & Livingstone, E., Sept 2023, In: European journal of cancer. 191, 112957.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (6)